, 2012), no experiments thus far have examined the pharmacological properties of such K2 artificial cannabinoids or their metabolites at CB2Rs. Thus, the goal of this research was to determine the affinity and intrinsic activity of JWH-018, JWH-073 and several other in their key phase I hydroxylated metabolites at human CB2Rs.These rarely extend be